February 07, 2023
Groups representing the domestic pharmaceutical industry lost their suit against a federal policy allowing states and tribes to import cheaper Canadian drugs, after a D.C. federal judge ruled the groups can't claim harm when no imports have been cleared yet.
November 24, 2020
An organization representing top pharmaceutical research firms and two health care advocacy groups have sued the Trump administration in D.C. federal court to block a new federal policy allowing states, tribes, pharmacists and wholesalers to import certain prescription drugs from Canada without approval from drug manufacturers.